Anondita Medicare Ltd
Founded in March 2024, Anondita Medicare Limited manufactures flavored male condoms, with its flagship product branded as “COBRA.”[1]
- Market Cap ₹ 1,505 Cr.
- Current Price ₹ 832
- High / Low ₹ 1,037 / 262
- Stock P/E 77.4
- Book Value ₹ 54.0
- Dividend Yield 0.00 %
- ROCE 62.1 %
- ROE 76.0 %
- Face Value ₹ 10.0
Pros
Cons
- Stock is trading at 15.2 times its book value
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 1m | Mar 2025 | |
|---|---|---|
| 0 | 61 | |
| 0 | 43 | |
| Operating Profit | 0 | 18 |
| OPM % | 30% | |
| 0 | 0 | |
| Interest | 0 | 3 |
| Depreciation | 0 | 1 |
| Profit before tax | 0 | 14 |
| Tax % | 25% | |
| 0 | 11 | |
| EPS in Rs | 0.00 | 8.12 |
| Dividend Payout % | 0% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| TTM: | % |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | % |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| Last Year: | 76% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | Sep 2025 | |
|---|---|---|---|
| Equity Capital | 0.10 | 13 | 18 |
| Reserves | 0 | 15 | 80 |
| 0 | 27 | 30 | |
| 0 | 9 | 15 | |
| Total Liabilities | 0 | 64 | 143 |
| 0 | 13 | 28 | |
| CWIP | 0 | 6 | 0 |
| Investments | 0 | 4 | 4 |
| 0 | 41 | 112 | |
| Total Assets | 0 | 64 | 143 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | |
|---|---|---|
| -0 | 6 | |
| 0 | -23 | |
| 0 | 17 | |
| Net Cash Flow | 0 | 0 |
| Free Cash Flow | -0 | -14 |
| CFO/OP | 36% |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2024 | Mar 2025 | |
|---|---|---|
| Debtor Days | 100 | |
| Inventory Days | 115 | |
| Days Payable | 45 | |
| Cash Conversion Cycle | 170 | |
| Working Capital Days | 101 | |
| ROCE % | 62% |
Insights
In beta| Jan 2026 | Mar 2027 (P) | |
|---|---|---|
| Installed Manufacturing Capacity million pieces per annum |
|
|
| Capacity Under Trial Production million pieces per annum |
||
| Existing Capacity Utilization million pieces per annum |
||
| Existing Capacity Utilization (%) % |
||
| IPO Proceeds Re-allocation to Working Capital INR Lakhs |
||
| IPO Proceeds Utilized (Total) INR Lakhs |
||
| IPO Unutilized Amount INR Lakhs |
||
| L1 GeM Tender Supply Volume (Condoms) pieces |
||
| L1 GeM Tender Supply Volume (Family Planning Items) pieces |
||
| Order Value (CMSS GeM Tender) INR |
||
| Projected Turnover for FY2025-26 INR Crores |
||
| Target Capacity Expansion (Noida Facility) million pieces per annum |
||
Documents
Announcements
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
13 April 2026 - Anondita Medicare confirms no Regulation 27 corporate governance compliance report required for quarter ended March 31, 2026.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
13 April 2026 - Submitted Regulation 74(5) confirmation certificate for quarter ended March 31, 2026.
-
Updates
6 April 2026 - Annual promoter and PAC declarations filed under SEBI Regulation 31(4) and 31(5) for FY2026.
-
Trading Window
27 March 2026 - Trading window closed April 1, 2026 until 48 hours after audited results for year ending March 31, 2026.
-
Updates
20 March 2026 - Anupam Ghosh purchased 26,000 shares (₹1,80,77,000); disclosure filed March 20, 2026.
Annual reports
No data available.
Concalls
-
Mar 2026TranscriptAI SummaryPPT
Business Profile[1]
Anondita Medicare manufactures male (and recently, female) condoms, flagship brand “COBRA,” with in-house printing/packaging and 100% electronic testing.